Abstracts tagged "Morbidity and mortality and psoriatic arthritis"

Abstract Number: 2136 • 2018 ACR/ARHP Annual Meeting
Mortality Rates and Causes in Psoriatic Arthritis Patients
Ofir Elalouf¹, Anastasiya Muntyanu², Daniel Pereira¹, Ari Polachek³, Justine Y. Ye⁴, Ker-Ai Lee⁵, Vinod Chandran⁴, Richard J. Cook⁵ and Dafna D Gladman¹, ¹Rheumatology, Toronto Psoriatic Arthritis Research Program, University of Toronto, University Health Network, Toronto, ON, Canada, ²University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ³Rheumatology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv Univrsity, Tel Aviv, Israel, ⁴Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁵Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada
Background/Purpose: Psoriatic arthritis (PsA) is an inflammatory musculoskeletal disease that affects about 30% of psoriasis patients, and can lead to significant joint damage and disability.…
Abstract Number: 2169 • 2018 ACR/ARHP Annual Meeting
Temporal Trends in Mortality in Patients Hospitalized for Cerebrovascular Events with Psoriatic Arthritis: Data from the Healthcare Cost and Utilization Project from 2010-2014
Shraddha Jatwani¹, Karan Chugh², Karan Jatwani³, Stuthi Perimbeti⁴, Vivek Modi⁵, Jasleen Kaur⁶ and Rakesh K Sharma⁷, ¹Department of Internal Medicine, Division of Rheumatology, Henry Ford Allegiance Health, Jackson, MI, ²Division of Pulmonary, Critical Care & Sleep, Wayne State University/Detroit Medical Center, Detroit, MI, ³Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital, New York, NY, ⁴Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital,, NEW YORK, NY, ⁵Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital,, New York, NY, ⁶Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, MI, ⁷Department of Medicine, Postgraduate Institute of Medical Education & Research, Chandigarh, India
Background/Purpose: Cerebrovascular disease risk in increased in patients of Psoriatic arthritis (PsA), as reported in the literature. Epidemiological studies to assesses average annual trends are…
Abstract Number: 2171 • 2018 ACR/ARHP Annual Meeting
A 5-Year National Trend in Acute Myocardial Infarctionamong Hospitalized Patients with Psoriatic Arthritis: Data from National Inpatient Sample
Shraddha Jatwani¹, Karan Chugh², Karan Jatwani³, Vivek Modi⁴ and Jasleen Kaur⁵, ¹Department of Internal Medicine, Division of Rheumatology, Henry Ford Allegiance Health, Jackson, MI, ²Division of Pulmonary, Critical Care & Sleep, Wayne State University/Detroit Medical Center, Detroit, MI, ³Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital, New York, NY, ⁴Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital,, New York, NY, ⁵Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, MI
Background/Purpose: Psoriatic arthritis (PsA) is associated with an increased risk of cardiovascular morbidity and mortality. The increase in cardiovascular risk evaluated in a meta-analysis on…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].